An RNAi therapeutic targeting antithrombin to rebalance the coagulation system and promote hemostasis in hemophilia
Nature Medicine2015Vol. 21(5), pp. 492–497
Citations Over TimeTop 1% of 2015 papers
Alfica Sehgal, Scott Barros, Lacramioara Ivanciu, Brian C. Cooley, June Qin, Tim Racie, Julia Hettinger, Mary Carioto, Yongfeng Jiang, Josh Brodsky, Harsha Prabhala, Xuemei Zhang, Husain Attarwala, Renta Hutabarat, Don Foster, Stuart Milstein, Klaus Charissé, Satya Kuchimanchi, Martin A. Maier, Lubo Nechev, Kandasamy Pachamuthu, Alexander V. Kel’in, Jayaprakash K. Nair, Kallanthottathil G. Rajeev, Muthiah Manoharan, Rachel Meyers, Benny Sørensen, Amy Simon, Yesim Dargaud, Claude Négrier, Rodney M. Camire, Akin Akinc
Related Papers
- Effect of dencichine on coagulation and the hemostatic mechanism(2014)
- Influence of fibrinogen derived antithrombin (antithrombin VI) on the blood coagulation system.(1959)
- [Studies on the autonomic nervous system control of the blood coagulation system; effect of the sympathetic block on blood coagulation factors and blood protein constituents].(1953)
- → Thermotolerance in Blood Coagulation under Hyperthermia.(1992)1 cited
- [Antithrombin III, the most important inhibitor of hemostasis. Physiology and clinical aspects].(1986)